$FFAI Cashflow Statement | Understand Stock

$FFAI

$0.56 -$0.06 (10.22%) Close

$FFAI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Amortization of operating lease right-of-use assets
Non-cash interest expense
Loss (gain) on digital assets, net
Loss (gain) on disposal of property and equipment, net
Change in fair value measurements
Nonrelated Party
Related Party
Total change in fair value measurements

Loss upon cancellation of a lease
Change in fair value measurement of related party notes payable and warrant liability
Change in fair value measurement of notes payable and warrant liability
Loss from failed sale leaseback arrangement
Loss on lease impairment
Asset impairment
Goodwill impairment
Stock-based compensation
Vesting of restricted stock awards for employee bonus
Recognition of lease impairment from sale leaseback arrangement
Reserve on inventory
Credit loss expense
Accrued interest on short-term note receivable
Loss on settlement of notes payable
Nonrelated Party
Related Party
Total loss on settlement of notes payable
Gain on forgiveness of vendor payables in trust
Reserve for unrecoverable value added taxes
Gain on foreign exchange
Loss (gain) on forgiveness of accounts payable and deposits, net (see Note 4)
H.S.L. SRL. settlement adjustment
Settlement on accrued research and development expenses
Change in fair value of notes payable, warrant liabilities, and derivative liabilities
Change in fair value of related party notes payable, warrant liabilities, and derivative liabilities
Other
Changes in operating assets and liabilities
Accounts receivables
Inventory
Deposits
Accounts payable
Accrued expenses and other current liabilities
Nonrelated Party
Related Party
Total accrued expenses and other current liabilities
Related party accrued interest expense
Nonrelated Party
Related Party
Financial obligations on lease back transaction
Operating lease liabilities
Accrued interest expense
Transfers between vendor payables in trust and accounts payable
Financing lease liabilities
Other current and non-current assets

Net cash used in operating activities
Cash flows from investing activities
Acquisition of AIXC, net of cash acquired
Proceeds from sale of equipment
Purchase of digital assets
Sale of digital assets
Payments for property and equipment
Proceeds from payments on notes receivable
Purchase of short-term note receivable
Additions to intangible assets
Net cash used in investing activities

Cash flows from financing activities
Proceeds from a sale and lease back transaction
Proceeds from AIXC follow-on capital contribution, net of issuance costs
Payments of notes payable issuance costs
Nonrelated Party
Related Party
Payments of notes payable and other financing obligations
Nonrelated Party
Related Party
Total payments of notes payable and other financing obligations
Payments of related party notes payable
Payments of notes payable issuance costs
Capital contributions
Proceeds from notes payable, net of original issuance discount
Nonrelated Party
Related Party
Total proceeds from notes payable, net of original issuance discount

Proceeds from exercise of warrants
Payments of capital lease obligations
Debt Conversion
Proceeds from exercise of stock options
Payments of vendor payables in trust
Transfers between vendor payables in trust and accounts payable
Proceeds from related party notes payable
Payments of stock issuance costs
Net cash provided by financing activities

Effect of exchange rate changes on cash and restricted cash
Net increase in cash and restricted cash
Cash and restricted cash, beginning of period
Cash and restricted cash, end of period
Cash and cash equivalents
Restricted cash
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of noncash investing and financing activities
Conversion of convertible note to equity
Additions of property and equipment included in accounts payable and accrued expenses
Issuance of SPA warrants, excluding Exchange Agreement (Note 7)
Issuance of Secured SPA Notes pursuant to the Exchange Agreement (Note 7)
Reclass of warrants from liability to equity
Conversion of notes payable and accrued interest into Class A Common Stock
Conversion of related party notes payable and related party accrued interest into Class A Common Stock
Conversion of notes payable and accrued interest to Class A Common Stock
Issuance of warrants
Conversion of assumed convertible and promissory notes payable to Class A Common Stock and Private Warrants
Conversion of assumed convertible and promissory notes payable into Class A Common Stock and Private Warrants
Conversion of related party customer deposit to related party notes payable

Exchange of shares
Class A Common Stock
Class B Common Stock
Settlement of vendor payable in trust to a commitment to issue Class A Common Stock
Settlement of notes payable and accrued interest for a commitment to issue Class A Common Stock
Settlement of related party notes payable and related party accrued interest for a commitment to issue Class A Common Stock
Settlement of vendor payables in trust for a commitment to issue Class A Common Stock
Reclassification of stock-based awards liability to equity due to authorized share increase
August 25, 2023
February 28, 2023
Reclassification of August 25, 2023 stock-based awards liability to equity due to authorized share increase
August 25, 2023
February 28, 2023
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares
Reduction in Warrants pursuant to the Exchange Agreement (Note 7)
Issuance of warrants and related party warrants with the SPA Portfolio Notes
Reduction in warrants pursuant to the Exchange Agreement
Reclassification of warrants from equity to liability
Reclassification of earnout shares liability to equity due to authorized share increase
August 25, 2023
February 28, 2023
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares
Settlement of vendor liability in Class A Common Stock
Non-cash warrant exercise activity and fair value reclassifications to equity
Additions of property and equipment included in accounts payable and accrued expenses
Write off of a finance lease pursuant to lease back transaction
Issuance pursuant to commitment to issue registered shares
Recognition of operating ROU assets and lease liabilities as part of the adoption of ASC 842 and for new operating leases entered into during the year ended December 31, 2022
Troubled debt restructuring accounted for as a capital transaction
Issuance of warrants
Liability for insufficient authorized shares related to stock options and restricted stock units
Liability for insufficient authorized shares related to earnout
Shares withheld for RSU tax obligations
Issuance of Exchange Note
Purchase of Class A Common Stock under the Salary Deduction and Stock Purchase Agreements
De-recognition of right-of-use assets and lease liabilities due to lease modifications
Receipt of class A Common Stock in consideration of exercises of options
Class A Common Stock to be delivered for conversion of notes payable (Note 10)
Transfer of private warrants to unaffiliated parties
Cancellation of warrants
Obtaining right-of-use asset in exchange for operating lease liabilities
Supplemental disclosure of noncash operating activities
Settlement of Palantir dispute with issuance of Class A Common Stock
Cash and restricted cash
Cash and cash equivalents
Restricted cash

Comments